AzTrials
AzTrials

Endotracheal IntubationDLETINCT02295657

Double Lumen Tube Intubation

A study testing standard double-lumen tube and VivaSight Double Lumen Tube in people with Endotracheal Intubation and Cardiac Arrest, run by International Institute of Rescue Research and Education at 1 site in Poland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study was to compare time, success rates of different double-lumen tubes in intubation in a standardized manikin model. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Endotracheal Intubation, Cardiac Arrest
What is being tested?
standard double-lumen tube and VivaSight Double Lumen Tube
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 sitePoland
Study dates
Nov 2014to Dec 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • give voluntary consent to participate in the study
  • minimum 1 year of work experience in emergency medicine
  • experienced emergency medicine personnel (physicians, nurses, paramedics)

Who cannot join

  • not meet the above criteria
  • wrist or low back diseases

Trial locations and contacts

1 site in 1 country.

Poland1 site, 1 recruiting
  • International Institute of Rescue Research and Education

    Warsaw, Masovia, 03-122

    Lukasz Szarpak, +48500186225, lukasz.szarpak@gmail.com

    Lukasz Szarpak

    Recruiting

Other trials in Poland

About this study

Official title: Comparison of Techniques for Double-lumen Tube Intubation: Standard Double-lumen Tube or VivaSight Double Lumen Tube by Paramedics. A Randomized Crossover Manikin Trial.

The aim of this study was to compare time, success rates of different double-lumen tubes in intubation in a standardized manikin model.

Being tested
standard double-lumen tube, VivaSight Double Lumen Tube
Medical subject headings
Heart Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • standard double-lumen tubeDevice

    intubation using standard double-lumen tube

  • VivaSight Double Lumen TubeDevice

    intubation using VivaSight Double Lumen Tube

Study groups in NCT02295657
Study groupRoleWhat they receive
ETI intubationExperimentalendotracheal intubation in manikin
Receives: Device: standard double-lumen tube; Device: VivaSight Double Lumen Tube

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Success of intubation

    effectiveness of first, second and third intubation attempts and overall effectiveness of intubation by participants

    Measured: 1 day

Secondary outcomes (3)
  1. Intubation time

    time in seconds required for a successful intubation attempt

    Measured: 1 day

  2. Cormack-Lehane grading

    self-reported percentage the vocal cord visualization using the Cormack-Lehane grading (grade 1-4)

    Measured: 1 day

  3. Preferred ETI device

    participants were asked which method of ETI they would prefer in a real-life.

    Measured: 1day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2014 (estimated)
  2. Study startNov 2014
  3. Primary completionDec 2014 (estimated)
  4. Study completionDec 2014 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02295657
Sponsor's protocol ID
ETI/2014/43
Acronym
DLETI
Status last verified
Nov 2014
First submitted
18 Nov 2014
Last updated
20 Nov 2014
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing standard double-lumen tube and VivaSight Double Lumen Tube in people with Endotracheal Intubation and Cardiac Arrest, run by International Institute of Rescue Research and Education at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Nov 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Andrzej Kurowski (+48500186225, andrzejkurowski987@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Success of intubation (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Nov 2014.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in